Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
ACC 2021: Findings from the WASE COVID Study
Author(s): Federico M Asch Added: 2 years ago
Dr Federico M Asch (MedStar Health Research Institute, Georgetown University, WA, US) discusses the results of a study comparing human vs machine learning-based echocardiography analysis applied as a predictor of outcomes in acute Covid-19 patients. Questions 1. What are the benefits of the machine learning approach in echocardiography analysis? 2. What is the WASE COVID Study? 3. What was the… View more

Imaging & Diagnostics

COVID-19
Prof Diana Gorog
Research Area(s) / Expertise:

Thrombosis, embolism & bleeding

Coronary Artery Disease and Myocardial Infarction

 Job title: Cardiologist and Clinical Lead for Non-cancer Research
Prof Diana Gorog holds academic appointments at the University of Hertfordshire and at the National Heart and Lung Institute of Imperial College, London, and is a full-time interventional consultant cardiologist at East and North Hertfordshire NHS Trust, UK. Prof Gorog graduated in Medicine from St. Bartholomew’s Medical School, University of London in1993 and undertook clinical training in… View more
Ghada Mikhail
Research Area(s) / Expertise:

Coronary Interventions

 Job title: Consultant cardiologist
Background Dr Ghada Mikhail is a consultant interventional cardiologist at Imperial College Healthcare NHS Trust. She qualified from the Royal Free Hospital School of Medicine, and was awarded an MD from the University of London. She trained at the Royal Brompton and Harefield NHS Trust. She has gained international experience by spending a year in Italy, in a world renowned centre, on an… View more
CardioNerds @AHA23: ORBITA-2: PCI for Stable Angina
Author(s): Rasha Al-Lamee , Christopher Rajkumar , Nazli Okumus Added: 5 months ago
AHA 2023 — Investigators of ORBITA-2 trial, Dr Rasha Al-Lamee and Dr Christopher Rajkumar (Imperial College London, UK) talked with CardioNerds Ambassador, Dr Nazli Okumus about the randomised, placebo-controlled trial (NCT03742050) that compared the effects of coronary angioplasty versus placebo procedure on symptoms of stable angina without background anti-anginal therapy at 12 weeks.The ORBITA… View more

Intervention
View from the Thoraxcenter: ESC 23 Late-breaking Science Wrap Up
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 7 months ago
What are the take-home messages from ESC 2O23? Join us as we delve into the pivotal results that ignited debates and discussions at ESC Congress 2023. Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) return with their "View from the Thoraxcenter" review, where they analyse the hot line and late-breaking trials presented in Amsterdam. In this ESC 2023… View more

Anticoagulation

Standards & Guidelines
TCT-Connect-2020-IREMMI-Trial-Rodrigo-Estévez-Loureiro
Added: 3 years ago
Dr Rodrigo Estévez-Loureiro (University Hospital Alvaro Cunqueiro, Vigo, SP) discusses the outcomes of MitraClip in patients with acute mitral regurgitation in AMI with and without cardiogenic shock. Questions 1. What is the background of the study? 2. How did you define cardiogenic shock? 3. What was the design, patient population and endpoints? 4. What were the key results? 5. What… View more

MI/ACS

Intervention
Author(s): Mahadevappa Mahesh Added: 3 years ago
Coronary artery disease (CAD) represents the major cause of morbidity and mortality in Western populations.1 The prime diagnostic tool that allowed the development of rational treatment techniques for this disease is invasive coronary angiography ((CA) an X-ray fluoroscopy guided procedure), which is associated with a low rate of life-threatening complications.2 More than 40% of the invasive CA… View more

Imaging & Diagnostics
Author(s): Raoul Bonan , Anita W Asgar Added: 3 years ago
Coronary angioplasty has revolutionized the treatment of coronary artery disease. Over the past two decades the field has seen numerous innovations in an attempt to perfect the percutaneous management of coronary atherosclerotic disease. The development of coronary stenting was a major advance in preventing elastic recoil and treating dissections following balloon angioplasty.1 Unfortunately,… View more

Intervention
Author(s): Deborah A Chyun Added: 3 years ago
Individuals with both type 1 and type 2 diabetes mellitus (DM) are known to be at high risk for developing coronary artery disease (CAD). The risk is two to three times greater in those with DM compared with those without, and is especially high in women with DM. An additional problem in individuals with DM is that, even with severe underlying CAD, many individuals may have atypical symptoms or… View more

Prevention & Chronic Conditions

MI/ACS
Author(s): Robert C Hendel Added: 3 years ago
Background Heart disease, specifically coronary artery disease (CAD), is the leading cause of death and disability among both men and women in the US. Reductions in blood supply due to narrowings of the arteries that supply the heart muscle with oxygen and nutrients (coronary arteries) result in chest pain and shortness of breath and may lead to permanent scarring of the heart muscle, as in the… View more

Imaging & Diagnostics